Drug Profile
BF-derm1
Alternative Names: BF-derm 1Latest Information Update: 20 Aug 2015
Price :
$50
*
At a glance
- Originator Biofrontera AG
- Class Skin disorder therapies
- Mechanism of Action Histidine decarboxylase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Chronic urticaria
Highest Development Phases
- Phase II Chronic urticaria